Maximize success in biotherapeutic antibody development

The demand for novel antibody formats is rising due to their increased use in disease treatment, targeting previously difficult-to-treat areas. Analytical technologies like Biacore™ SPR systems by Cytiva play a significant role in guiding decision-making throughout the development process, from candidate selection to clinical lead. This application note delves into the journey of creating a suitable clinical lead molecule and evaluating the downstream potential of new therapeutics through candidate optimization.